OELKE MATHIAS

PrivateCIK: 1921607
Location

GAITHERSBURG, MD

OELKE MATHIAS enters NEXIMMUNE, INC. with 7.92K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderOELKE MATHIASCIK 1921607
IssuerNEXIMMUNE, INC.CIK 1538210
Officer· Chief Science Officer
Since Apr 2022
7.92K
Baseline shares
100% direct
7.92K
Direct ownership
1 position
234.83K
Derivative underlying
6 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned7.92K
Total
7.92K direct7.92K
Derivative Holdings6

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

19.91K

Shares owned

N/A

Exercise price

17.00

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

115.05K

Shares owned

N/A

Exercise price

2.58

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

47.38K

Shares owned

N/A

Exercise price

2.42

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

4.75K

Shares owned

N/A

Exercise price

2.58

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

15.79K

Shares owned

N/A

Exercise price

2.42

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

31.95K

Shares owned

N/A

Exercise price

4.31

Expiration

Exercise window

Total

Underlying

234.83K

Owned

0.00

OELKE MATHIAS — Initial Ownership Disclosure (Form 3) Filed Apr 7, 2022 | Finecho